A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer
Clinical trial NCT03726294 · COMPLETED
Trial details
- NCT number
- NCT03726294
- Sponsor
- NatureWise Biotech & Medicals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2020-04-24
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.